Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Will 2017 be a Black Swan year?

Posted on February 6th, 2017 by in Pharma R&D

A few years ago, I sat with some friends aiming to make predictions for the year ahead. Our goal was to see how close we could get, with a plan to review the following new year. We made several predictions for the world of science Continue reading “Will 2017 be a Black Swan year?” »

New Developments in R&D

Posted on January 11th, 2017 by in Pharma R&D

There are some exciting changes happening at Rubius right now. We moved into a new lab,  and  more importantly, we’ve hired a new vice president of R&D, Tom Wickham. Continue reading “New Developments in R&D” »

Medicine Non-adherence: Time for a Personalized Healthcare Approach?

Posted on December 19th, 2016 by in Pharma R&D

It was interesting to note the article from Beth Snyder Bulik (1) that patient non-adherence to taking their prescribed medicines not only has a potential impact on their health and wellbeing, it also impacts the companies’ and healthcare providers’ bottom lines. Continue reading “Medicine Non-adherence: Time for a Personalized Healthcare Approach?” »

India: Emerging Hub of Pharmaceutical R&D

Posted on November 7th, 2016 by in Pharma R&D

For many of the last five decades, India has been known as the largest exporter of generic drugs, particularly to the United States. However, today, in 2016, India is getting to be known for a bit more than that: Continue reading “India: Emerging Hub of Pharmaceutical R&D” »

  1. 1
  2. 2